Back to Peptides

BPC-157

Extensively Studied

Body Protection Compound-157 | Pentadecapeptide

Dose 250-500mcg
Frequency Once or twice daily
Cycle 4-12 weeks depending on injury
Storage Lyophilized: freezer long-term. Reconstituted: 2-8°C for 4-6 weeks

Synthetic peptide derived from gastric juice protein, renowned for tissue repair, inflammation reduction, and GI protection capabilities. BPC-157 promotes blood vessel formation, enhances collagen synthesis, modulates growth factor expression, and protects against tissue damage through localized or systemic delivery.

Mechanism of Action

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways.

Key Benefits

  • Accelerated tendon, ligament, muscle, and bone healing
  • Localized tissue repair with direct targeting
  • Superior bioavailability
  • Anti-inflammatory effects
  • Angiogenesis promotion
  • Gastric and intestinal protection
Molecular Weight
1,419.53 Da
Chain Length
15 amino acids
Type
Pentadecapeptide
Amino Acid Sequence
One-letter: GKPPPGKPADDAGLV
H₂N
H
G 1
O C
N
K 2
O C
N
P 3
O C
N
P 4
O C
N
P 5
O C
N
H
G 6
O C
N
K 7
O C
N
P 8
O C
N
A 9
O C
N
D 10
O C
N
D 11
O C
N
A 12
O C
N
H
G 13
O C
N
L 14
O C
N
V 15
COOH
Gly
1

Glycine

Position 1

Lys
2

Lysine

Position 2

Pro
3

Proline

Position 3

Pro
4

Proline

Position 4

Pro
5

Proline

Position 5

Gly
6

Glycine

Position 6

Lys
7

Lysine

Position 7

Pro
8

Proline

Position 8

Ala
9

Alanine

Position 9

Asp
10

Aspartic Acid

Position 10

Asp
11

Aspartic Acid

Position 11

Ala
12

Alanine

Position 12

Gly
13

Glycine

Position 13

Leu
14

Leucine

Position 14

Val
15

Valine

Position 15

N-terminus C-terminus
Hydrophobic
Polar
Positive (+)
Negative (-)
Modified

Wound Healing

  • Tendon Healing

    Accelerated tendon-to-bone healing with improved biomechanical properties; most effective with localized injection.

  • Muscle Recovery

    Enhanced healing and reduced recovery following crush injuries and surgical procedures with direct tissue targeting.

  • Angiogenesis

    Promotes blood vessel formation and improves vascularization through localized delivery.

Neurological

  • Neuroprotection

    Protective effects against neurotoxic agents and ischemic brain injury models.

  • Spinal Cord Injury

    Improved functional recovery and reduced tissue damage in spinal cord injury studies.

  • Peripheral Nerves

    Enhanced peripheral nerve regeneration and functional recovery after injury.

Gastrointestinal

  • Ulcer Protection

    Protective effects against gastric and duodenal ulcers through cytoprotective mechanisms.

  • Intestinal Repair

    Acceleration of intestinal healing with reduced inflammatory markers in IBD models.

  • Mucosal Healing

    Enhanced mucosal barrier function and accelerated epithelial regeneration.

Most effective for localized healing when injected near injury site. Subcutaneous injection preferred for targeted tissue repair.

GoalDoseFrequencyRoute
Tendon/Joint healing250-500 mcg1-2x dailySubQ near injury
Serious injury500-1000 mcg2x dailySubQ near injury
General healing250-500 mcg1-2x dailySubQ or IM
Maintenance250 mcg1x dailySubQ

Reconstitution Instructions

Materials Needed:
  • Bacteriostatic water (BAC)
  • Insulin syringes (0.5-1 mL)
  • Alcohol swabs
  • Peptide vial
  • Sterile work surface
  1. 1 Clean work area and hands thoroughly
  2. 2 Calculate required BAC water volume using calculator
  3. 3 Draw BAC water into syringe
  4. 4 Inject slowly down vial side (not directly onto powder)
  5. 5 Gently swirl until dissolved (never shake)
  6. 6 Store in refrigerator, use within 28 days
TB-500

Complementary healing mechanisms; often used together in the Wolverine Stack.

synergistic
GHRP-6

No known negative interactions.

compatible
Ipamorelin

BPC-157 increases GH receptor expression, amplifying growth hormone benefits.

synergistic
CJC-1295

BPC-157 upregulates GH receptors, enhancing effectiveness for tissue repair.

synergistic
Melanotan II

No known interactions; different mechanisms and receptor targets.

compatible
AOD-9604

Safe combination; different pathways. Often combined in regenerative protocols.

compatible
Week 1-2

Reduced inflammation and pain at injection site

Week 2-4

Improved healing rate and tissue repair

Week 4-8

Maximum localized healing benefits

Common Side Effects

  • Mild injection site redness
  • Injection site irritation
  • Possible mild digestive adjustment (oral)

Stop Signs - Discontinue if:

  • Persistent injection site reactions or infection signs
  • Unusual swelling or rash around injection area
  • Severe headaches or dizziness
  • Allergic reactions
  • Persistent or worsening digestive issues

Contraindications

  • Active cancer (due to angiogenic effects)
  • Pregnancy or breastfeeding
  • Blood thinners (consult doctor due to angiogenesis)
  • WADA prohibited for competitive athletes

Good Signs

  • White, fluffy lyophilized powder (cake) filling vial bottom
  • Crystal clear solution after reconstitution with no particles
  • Intact vacuum seal on vial

Warning Signs

  • Slight clumping that dissolves with gentle swirling (acceptable from shipping)

Bad Signs

  • Collapsed, melted, or powder stuck to vial sides (heat exposure)
  • Cloudy solution, particles, or precipitates after reconstitution
  • Discoloration of powder
  • Achilles Tendon Healing Study
    (2003)

    Superior tendon healing with improved biomechanical properties and enhanced tendon-to-bone integration in rat models.

  • Muscle Healing Research
    (2006)

    Accelerated quadriceps healing with improved histology, reduced inflammation, and restored function in rat models.

  • Spinal Cord Injury Recovery
    (2019)

    Significant functional recovery, reduced tissue damage, and improved neurological outcomes in rat models.

  • Gastric Ulcer Protection
    (2020)

    Cytoprotective effects against gastric ulcers through multiple protective mechanisms.

  • VEGF and Angiogenesis Study
    (2017)

    Pro-angiogenic effects via VEGFR2 activation, explaining wound healing mechanisms.

  • Safety Evaluation Study
    (2020)

    No serious adverse effects at therapeutic doses up to 1000 μg/kg for 90 days; established safety profile.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.